• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

How Has COVID-19 Impacted the Allergy and Immunology Field?


Courtney Blair, MD, discusses how COVID-19 has impacted patients with allergies and other respiratory conditions.

With unprecedented pauses in air pollution emissions seen around the world in the spring of 2020 and virus mitigation behaviors being implemented for over a year, the COVID-19 pandemic has presented a unique opportunity to better understand the impact of poor air quality on human health.

In particular, exposure reduction due to mask-wearing and stay-at-home orders has contributed to anecdotal reports of reduced exacerbations among patients with chronic obstructive pulmonary disease (COPD), asthma, allergies, and other respiratory conditions.

To learn more about how the pandemic has altered care and disease management among these patients, we spoke with Courtney Blair, MD, an allergist and immunologist in Virginia.

On this episode of Managed Care Cast, Blair, who also serves as the president of the Greater Washington Allergy, Asthma, and Immunology Society, discusses factors that may have contributed to improvements in her patients’ respiratory health over the past 15 months.

Listen above or through one of these podcast services:


Related Videos
Bevey Miner, executive vice president of health care strategy and policy, Consensus Cloud Solutions
dr parth rali
Dr Jeffrey Sippel
dr kimberly maxfield
Related Content
© 2023 MJH Life Sciences
All rights reserved.